Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study - Concepedia

Concepedia

Publication | Open Access

Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study

DOI Full Paper Access

20

Citations

25

References

2021

Year

Issaka Sagara, John Woodford, Mamady Koné, Mahamadoun H. Assadou, Abdoulaye Katilé, Oumar Attaher, Amatigué Zéguimé, M’Bouye Doucoure, Emily Higbee, Jacquelyn Lane,

Unknown Venue

Abstract

This project was funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering, and National Cancer Institute.

References

	Year	Citations
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection Jennifer M. Dan, José Mateus, Yu Kato, Science	2021	3K
Limit of blank, limit of detection and limit of quantitation. David Armbruster, Terry Pry PubMed EngineeringMeasurementMedicineBioanalysisBlank Sample	2008	2.1K
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence Éster Cerdeira Sabino, Lewis Buss, Maria P. S. S. Carvalho, The Lancet High SeroprevalenceGlobal HealthGlobal Health CrisisCovid-19 PandemicCovid-19 Epidemiology	2021	879
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Victoria Hall, Sarah Foulkes, André Charlett, The Lancet Long CovidSars-cov-2 Infection RatesCovid-19 PandemicInfection ControlAntibody-negative Health-care Workers	2021	732
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic Lewis Buss, Carlos A. Prete, Claudia M. M. Abrahim, Science	2021	539
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors Sophie Uyoga, Ifedayo Adetifa, Henry Karanja, Science	2020	339
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection Raymond A. Harvey, Jeremy A. Rassen, Carly Kabelac, JAMA Internal Medicine	2021	282
High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa For Yue Tso, Salum J. Lidenge, Phoebe B. Peña, International Journal of Infectious Diseases	2020	257
Why is There Low Morbidity and Mortality of COVID-19 in Africa? M. Kariuki Njenga, Jeanette Dawa, Mark Nanyingi, American Journal of Tropical Medicine and Hygiene VaccinationVirus EpidemiologyGlobal HealthGlobal Health CrisisEpidemiological Dynamic	2020	190
Estimated Incidence of Coronavirus Disease 2019 (COVID-19) Illness and Hospitalization—United States, February–September 2020 Heather E. Reese, A. Danielle Iuliano, Neha Patel, Clinical Infectious Diseases	2020	189

Page 1